Financial Disclosure Statement

MSACL 2018 US Abstract Title:
Confirming 23-Benzodiazepines in Urine for Pain Management Using LC-MS/MS – a Challenging Assay Development
Richard Lahr
Development Technologist, Mayo Clinic

DescriptionY/NSource
Grantsno
SalaryyesMayo Clinic, Rochester, MN
Board Memberno
Stockno
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no